NCT01374178View on ClinicalTrials.gov

A Comparison of LY2963016 to a Basal Insulin After a Single Dose in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Diabetes Mellitus
Interventions
DRUG

LY2963016

Administered subcutaneously

DRUG

Lantus

Administered subcutaneously

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01374178 - A Comparison of LY2963016 to a Basal Insulin After a Single Dose in Healthy Subjects | Biotech Hunter | Biotech Hunter